more susceptible to this induced rejuvenation and whether the rejuvenation of all organs is necessary for the lifespan effect. It is possible that rejuvenation of a central organ may help the entire organism, perhaps via systemic factors. Organ-specific induction of the four factors could expand our understanding of the organs that are critical for aging and that may drive the aging process of the whole organism. Also, as most age-associated features investigated in this study are related to DNA damage and cellular senescence, it would be interesting to determine how reprogramming could affect senescent cells in a tissue and if reprogramming potentially induces their selective killing. It would be interesting to combine this reprogramming approach with drugs that target senescent cells (senolytic) or with genetic models for elimination of senescent cells in vivo (Trabucco and Zhang, 2016) . Testing the interaction between the two approaches could tease out whether the reprogramming factors mainly act by impacting the senescent cells and/or if it has additional beneficial effects.
The burning question is naturally whether this approach may also benefit human health and lifespan. The authors provide some initial observations that late-passage fibroblasts (redifferentiated from human iPSCs) exhibit a similar reversion in age-associated features upon short-term induction of the four factors. Although preliminary, these results suggest that these findings can be extended to human cells. A similar inducible whole-organism system in humans would be difficult to implement, yet future applications could involve more targeted approaches in key failing organs using non-invasive methods or the identification of compounds that can mimic it. A more extensive investigation of the risks associated with this approach would also be needed, especially in regard to tumor development in normal organisms. Because epigenetic changes appear to play a role early in the process, drugs that modulate specific epigenetic modifiers could be used, if targeted appropriately, as a way to mimic transient reprogramming. In addition, specific compounds or small RNAs that have been shown to enable reprogramming without exogenous gene expression (Takahashi and Yamanaka, 2016) could also be used to transiently ameliorate tissue functions without inducing dedifferentiation, thereby increasing the spectrum of therapies for progeroid diseases and even physiological aging.
